The PEA3 subfamily of Ets transcription factors synergizes with β-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors

Molecular and Cellular Biology

Volumn 21, Issue 4, 2001, Pages 1370-1383

  Crawford, H C ^a   Fingleton, B ^a   Gustavson, M D ^a   Kurpios, N ^a   Wagenaar, R A ^a   Hassell, J A ^a   Matrisian, L M ^a  

^a MCN T2219 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LUCIFERASE; MATRILYSIN; MATRIX METALLOPROTEINASE; PROTEIN C JUN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; COLON ADENOMA; COLON CARCINOGENESIS; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE TUMOR; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BETA CATENIN; BINDING SITES; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DNA PRIMERS; DNA-BINDING PROTEINS; GENES, REPORTER; HUMANS; INTESTINAL NEOPLASMS; LUCIFERASES; LYMPHOID ENHANCER-BINDING FACTOR 1; MATRIX METALLOPROTEINASE 7; MICE; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035141323     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.4.1370-1383.2001     Document Type: Article

References (58)

1. Cadherin-catenin complex: Protein interactions and their implications for cadherin function
2. Functional interaction of beta-catenin with the transcription factor LEF-1
3. The AP-1 site and MMP gene regulation: What is all the fuss about?
4. β-Catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator
5. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
6. A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus
7. Drosophila Tcf and Groucho interact to repress Wingless signalling activity
8. Transforming growth factors and related peptides in gastrointestinal neoplasia
9. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors
10. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells
11. Oncogene-initiated aberrant signaling engenders the metastatic phenotype: Synergistic transcription factor interactions are targets for cancer therapy
12. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin
13. Structure and expression of the human gene for the matrix metalloproteinase matrilysin
14. Overview of matrix metalloproteinase expression in cultured human cells
15. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions
16. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression
17. Specificity within the ets family of transcription factors
18. Nuclear targets for transcriptional regulation by oncogenes
19. Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors
20. Identification of c-MYC as a target of the APC pathway
21. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates
22. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover
23. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription
24. Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension
25. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1
26. Beta-catenin mutations in cell lines establihshed from human colorectal cancers
27. Lessons from hereditary colorectal cancer
28. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
29. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression
30. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma
31. Alternative splicing within the chicken c-ets-1 locus: Implications for transduction within the E26 retrovirus of the c-ets proto-oncogene
32. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
33. Structural basis for DNA bending by the architectural transcription factor LEF-1
34. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements
35. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas
36. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
37. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription
38. Deletion of an amino-terminal sequence stabilizes β-catenin in vivo and promotes hyperphosphorylation of the adenomatous polyposis coli tumor suppressor protein
39. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
40. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300
41. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
42. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A
43. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1
44. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: Stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody
45. Matrilysin and cyclooxygenase-2 are differentially expressed in intestinal and colorectal neoplasms
46. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice
47. Analysis of E1A-mediated growth regulation functions: Binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity
48. The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression
49. Matrilysin gene expression in sporadic and familial colorectal adenomas
50. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
51. Combinatorial chemoprevention of intestinal neoplasia
52. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors
53. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway
54. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
55. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse
56. AP-1: One switch for many signals
57. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo
58. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate